Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura (HERCULES trial). | Transfus Med;29(3): 146-148, 2019 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura (HERCULES trial).

Estcourt, L J.

Affiliation

Estcourt LJ; Radcliffe Department of Medicine and BRC Haematology Theme, John Radcliffe Hospital, Oxford, UK.

Transfus Med ; 29(3): 146-148, 2019 Jun.

Article in En | MEDLINE | ID: mdl-31318128

Subject(s)
Key words

RCT; caplacizumab; plasma exchange; thrombotic thrombocytopenic pupura

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Purpura, Thrombotic Thrombocytopenic / Single-Domain Antibodies Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: Transfus Med Journal subject: HEMATOLOGIA Year: 2019 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Purpura, Thrombotic Thrombocytopenic / Single-Domain Antibodies Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: Transfus Med Journal subject: HEMATOLOGIA Year: 2019 Document type: Article Affiliation country: Country of publication: